Table 1.
Binding affinities and selectivities of I2 receptor agonists at I1, I2 receptors and α2 adrenoceptors
| Drug | I1 (Ki or IC50, nM) | I2 (Ki, nM) | α2 (Ki, nM) | I2/I1 | I2/α2 | References |
|---|---|---|---|---|---|---|
| Tracizoline | 19.1 | 1.9 | 14,118 | 10 | 7431 | Polidori et al. (2000); Gentili et al. (2006) |
| 2-BFI | 6392* | 1.3 | 3,736 | 4917 | 2874 | Hudson et al. (1997) |
| BU224 | 1747 | 2.1 | 2,231 | 832 | 1062 | Hudson et al. (1999) |
| Phenyzoline | 3697 | 2.5 | 1,985 | 1479 | 794 | Gentili et al. (2006; 2008) |
| S22687 | 370 | 45 | 11,000 | 8 | 244 | Barrot et al. (2000) |
| Diphenyzoline | 6340 | 158.5 | 7,079 | 40 | 45 | Gentili et al. (2006; 2008) |
| CR4056 | ND | 596 (IC50) | N.D, but inactive at 10 µM | – | Ferrari et al. (2011) | |
| Idazoxan | 1259 | 10.6 | 55.4 | 119 | 5 | Hudson et al. (1997); Eglen et al. (1998) |
| Efaroxan | 52 | >10,000 | 13 | <0.005 | <0.001 | Eglen et al. (1998) |
Selectivity (I2/I1 or I2/α2) was determined by comparing the Ki or IC50 values of the compounds on both receptors.
Personal communication with Dr Alan L. Hudson, University of Alberta.
ND, not determined.